Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
BioSpace
Checkmate Pharmaceuticals Announces Additions to Management Team
October 15, 2019 -
GlobeNewswire
Ultragenyx Announces FDA Accepts New Drug Application for UX007 (triheptanoin) for Treatment of Long-chain Fatty Acid Oxidation Disorders
October 14, 2019 -
BioSpace
Menlo Therapeutics Presents Successful Phase 2 Clinical Trial Results of Serlopitant in Psoriasis at the European Academy of Dermatology and Venereology Meeting
October 11, 2019 -
PR Newswire
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
October 10, 2019 -
PR Newswire
Protenus Focuses on Customers and Compliance With New Additions of Chief Customer Officer and Vice President of Legal
October 10, 2019 -
Business Wire
Beam Therapeutics Appoints Graham Cooper to Board of Directors
October 10, 2019 -
PR Newswire
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
October 9, 2019 -
GlobeNewswire
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
October 9, 2019 -
Forbes
AI Startup Working To Target Cancer, Age-Related Disease Gets $37 Million Nod From Top VCs
October 9, 2019 -
Fierce Biotech
Owkin’s mesothelioma AI discovers new biomarkers from lung biopsy images
October 7, 2019 -
Business Wire
Lafayette General Health to Elevate Consumer Digital Experience and Launch Online Scheduling with Kyruus
October 7, 2019 -
CNBC
Private Medicare plan Devoted Health says it is the first to cover Apple Watch as a benefit
October 7, 2019 -
GlobeNewswire
Tempest Therapeutics Names Biopharmaceutical Executive Stephen Brady as President and Chief Operating Officer
October 7, 2019 -
PRWeb
Vitalware’s Tara Bradley Named Finalist in 16th Annual Stevie® Awards for Women in Business
October 7, 2019 -
VerveTx
Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer
October 3, 2019 -
Business Wire
Banner Health Launches Online Scheduling for Consumers with Kyruus
October 3, 2019 -
MobiHealthNews
Cloud management tool for dental practices CareStack lands $28M
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Appointment of CEO Mark Rothera to The Alliance for Regenerative Medicine’s 2020 Board of Directors
October 2, 2019 -
GlobeNewswire
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
October 2, 2019 -
PR Newswire
TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain
October 2, 2019 -
GlobeNewswire
Tempest Therapeutics Announces Multiple Presentations at Upcoming Sitc 34th Annual Meeting
October 2, 2019 -
Business Wire
Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001
October 1, 2019 -
PR Newswire
Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
October 1, 2019 -
Oxford Nanopore
Oxford Nanopore enters into a non-exclusive agreement with Caribou Biosciences for CRISPR-Cas9 enrichment for nanopore sequencing
September 30, 2019 -
GlobeNewswire
Menlo Therapeutics Announces Completion of Enrollment of 233 Patients in Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
September 30, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)
September 30, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress
September 30, 2019 -
Business Standard
Eywa aims to make mark in US market with own label, skip generic trend
September 28, 2019 -
GlobeNewswire
Acacia Pharma Announces New BARHEMSYS® PDUFA Target Date of 26 February 2020
September 26, 2019 -
Newswire
Artemis Health Wins 2019 SaaS Award From Appealie
September 26, 2019 -
GlobeNewswire
Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer
September 23, 2019 -
Business Wire
Nebula Genomics Launches Anonymous Genetic Testing
September 19, 2019 -
PR Newswire
Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO
September 19, 2019 -
PR Newswire
Benchling Launches New Products for Research Institutions and Biotech Startups to Accelerate Life Science Innovation
September 17, 2019 -
genomeweb
LunaPBC Partners With Medfusion to Integrate EHR, Genomic Data-Sharing Platform
September 17, 2019 -
PR Newswire
Firefly Health Closes $10.2 Million Series A Funding Round to Expand New Primary Care and Patient Experience Platform
September 16, 2019 -
GlobeNewswire
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy
September 16, 2019 -
Business Wire
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board
September 16, 2019 -
Business Wire
Devoted Health and Publix Team Up to Improve Flu Vaccination Coverage in Florida
September 12, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
September 10, 2019 -
BioSpectrum
Insilico Medicine secures $37M in series B funding
September 10, 2019 -
PR Web
CareStack and ClearGage Announce Technology Integration
September 10, 2019 -
GlobeNewswire
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
September 9, 2019 -
GlobeNewswire
United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4
September 9, 2019 -
Fierce Biotech
Insilico’s AI networks generate custom lead compounds for fibrosis in less than 50 days
September 4, 2019 -
GlobeNewswire
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
September 4, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
September 4, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)
September 4, 2019 -
Business Wire
Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer
September 4, 2019 -
Business Wire
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Additional Coordinated Care in Arizona, Georgia and Texas
September 4, 2019 -
Fierce Biotech
Biotech Vertex plunks down $950M for stem cell player Semma Therapeutics
September 3, 2019 -
GlobeNewswire
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
September 3, 2019 -
GlobeNewswire
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
August 27, 2019 -
PR Newswire
Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare
August 26, 2019 -
Fierce Biotech
Zogenix pays $250M upfront for startup Modis and its FDA ‘breakthrough’ med
August 26, 2019 -
Endpoint News
Modis Therapeutics -$30M launch round to $400M buyout deal — with $250M upfront — in 10 short months
August 26, 2019 -
PR Newswire
Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors
August 22, 2019 -
PR Newswire
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
August 21, 2019 -
Newswire
Healthcare Embracing New Era of Compliance and Analytics
August 20, 2019 -
STAT
Can targeting one protein complex solve multiple diseases? NodThera is betting on it
August 16, 2019 -
PR Newswire
Vitalware Named to the 2019 Inc. 5000 Fastest Growing Private Companies List for Fifth Consecutive Year
August 15, 2019 -
GlobeNewswire
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
August 14, 2019 -
PR Newswire
Iora Health Hires New Chief Operating Officer, Suzanne Hansen
August 13, 2019 -
Business Wire
Kyruus ProviderMatch® Patient Access Platform Now Powering Patient-Provider Matching at Norton Healthcare
August 6, 2019 -
PR Newswire
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
August 5, 2019 -
GlobeNewswire
Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders
August 1, 2019 -
PR Newswire
Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome
July 29, 2019 -
GlobeNewswire
Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS
July 25, 2019 -
PR Newswire
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
July 24, 2019 -
PR Newswire
Benchling Raises $34.5M Series C To Fuel Life Sciences R&D
July 24, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer
July 22, 2019 -
GlobeNewswire
Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center
July 22, 2019 -
Business Standard
Caplin Steriles gets USFDA approval for Tranexamic Acid Injection
July 18, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies
July 18, 2019 -
PR Newswire
TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform
July 18, 2019 -
GlobeNewswire
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States
July 18, 2019 -
GlobeNewswire
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
July 18, 2019 -
PR Newswire
Protenus Named 2019 Top Patient Privacy Solution by Black Book Market Research
July 11, 2019 -
PR Newswire
Embark Unleashes New, Best In Class Canine DNA Breed Identification Kit
July 9, 2019 -
GlobeNewswire
Pulmocide announces Scientific Reports (Nature Research) publication showing PC945 in combination with standard antifungal treatment causes a synergistic effect against Aspergillus fumigatus
July 2, 2019 -
PR Newswire
LunaPBC Named 2019 World Economic Forum Technology Pioneer
July 1, 2019 -
Business Wire
Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes
July 1, 2019 -
Nasdaq
Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab
June 27, 2019 -
PR Newswire
Novaerus Joins Clean Hospitals
June 20, 2019 -
Zacks Equity Research
Ultragenyx & Arcturus Therapeutics Expand Existing Agreement
June 20, 2019 -
Business Wire
Kyruus and Brandify Form Partnership to Help Health Systems Boost Brand Visibility and Patient Acquisition Online
June 18, 2019 -
Business Wire
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471
June 17, 2019 -
PR Newswire
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
June 17, 2019 -
Business Wire
Signaling Industry-Wide Shift to Integrated Mental Health, Quartet Announces Capital Raise and Strategic Partnership with Leading Medicaid Provider
June 13, 2019
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.